Cart
sales@molnova.com
Home - Products - Autophagy - CXCR - MSX-130

MSX-130

CAS No. 4051-59-6

MSX-130( MSX-130 | MSX 130 | MSX130 )

Catalog No. M17502 CAS No. 4051-59-6

MSX-130 is CXCR4 Antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
10MG 140 In Stock
25MG 267 In Stock
50MG 500 In Stock
100MG 705 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    MSX-130
  • Note
    Research use only, not for human use.
  • Brief Description
    MSX-130 is CXCR4 Antagonist.
  • Description
    MSX-130 is CXCR4 Antagonist.
  • In Vitro
    The C-X-C chemokine receptor-4 (CXCR4) is a seven trans-membrane G-protein coupled receptor (GPCR) classified as a member of the family I GPCR or rhodopsin-like GPCR family. CXCR4 plays an important role in cancer metastasis, regulation of stem cell trafficking, and neovascularization.
  • In Vivo
    ——
  • Synonyms
    MSX-130 | MSX 130 | MSX130
  • Pathway
    Autophagy
  • Target
    CXCR
  • Recptor
    CXCR4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4051-59-6
  • Formula Weight
    514
  • Molecular Formula
    C36H26N4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 2 mg/mL (3.89 mM)
  • SMILES
    c1(ccc(cc1)c1nc(c([nH]1)c1ccccc1)c1ccccc1)c1[nH]c(c(n1)c1ccccc1)c1ccccc1
  • Chemical Name
    2,2'-(1,4-Phenylene)bis[4,5-diphenyl-1H-imidazole]

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Weiqiang Zhan, et al. Discovery of Small Molecule CXCR4 Antagonists. J. Med. Chem., 2007, 50 (23), pp 5655–5664.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Eldelumab

    Eldelumab (BMS-936557) is a humanized anti-IP-10 IgG type 1 monoclonal antibody with inhibitory activity against CXCL10. It has anti-inflammatory properties, selectively binds to CXCL10, and can be used in the study of rheumatoid arthritis, ulcerative colitis, and Crohn's disease.

  • Ulocuplumab

    Ulocuplumab (BMS-936564) is a fully human anti-CXCR4 IgG4 antibody.Ulocplumab exhibits antitumor activity in acute myeloid leukemia (AML), non-Hodgkin's lymphoma (NHL), and multiple myeloma transplantation models.

  • CXCR7 antagonist-1

    CXCR7 antagonist-1 is a specific antagonist of the binding of the SDF-1 chemokine or I-TAC to the chemokine receptor CXCR7.

Sign In Join Free